Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H25N3O |
| Molecular Weight | 323.432 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)[C@@H]1CN(C)[C@@H]2CC3=CNC4=C3C(=CC=C4)C2=C1
InChI
InChIKey=VAYOSLLFUXYJDT-KBXCAEBGSA-N
InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18+/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. | 2004-08 |
|
| High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action. | 1999-05 |
|
| Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. | 1993-09-15 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
R1XBQ6NTFR
Created by
admin on Mon Mar 31 17:35:45 GMT 2025 , Edited by admin on Mon Mar 31 17:35:45 GMT 2025
|
PRIMARY | |||
|
DTXSID30858950
Created by
admin on Mon Mar 31 17:35:45 GMT 2025 , Edited by admin on Mon Mar 31 17:35:45 GMT 2025
|
PRIMARY | |||
|
2126-78-5
Created by
admin on Mon Mar 31 17:35:45 GMT 2025 , Edited by admin on Mon Mar 31 17:35:45 GMT 2025
|
PRIMARY | |||
|
638252
Created by
admin on Mon Mar 31 17:35:45 GMT 2025 , Edited by admin on Mon Mar 31 17:35:45 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
